Blood platelet behaviour was studied in six patients during infusion of an Intralipid-based intravenous feeding mixture. Lower concentrations of sodium arachidonate were required to induce platelets to aggregate and to undergo a release reaction during intravenous feeding than were required before or after intravenous feeding. This change was not due to a change in serum albumin level. The platelet behaviour that was induced by adenosine diphosphate or by adrenaline remained unchanged during intravenous feeding.
Introduction
The first fat emulsions to be used extensively for intravenous feeding were found to be toxic. Among the various side effects were bleeding phenomena that were associated with coagulation defects, and thrombocytopenia. Although modern fat emulsions such as Intralipid are considered to be safe, there has been one report of thrombocytopenia after prolonged use (Lipson, 1974) . Fat emulsions may lead to thrombocytopenia through an effect on platelet function and Atik (1976) has suggested that evaluation of platelet function in conjunction with current and future fat emulsions for human use is to be recommended.
Intravenous nutrition can be simplified if Intralipid is mixed with other nutrients in a single 3-litre bag before infusion (Burnham et al., 1981) . The purpose of the present study was to compare blood platelet behaviour before, during and after infusion of the mixture that is currently being used.
Materials and methods Patients
Six patients who required intravenous nutrition were studied. Five of the patients had inflammatory bowel disease requiring surgery; the other had a diverticular abscess and intestinal obstruction. The ages of the patients ranged from 27 to 67 years (mean 49 years). The duration of intravenous feeding, together with the points at which surgery was performed and the points at which blood samples for the platelet studies were withdrawn, are summarized in Fig. 1 (Heptinstall and Mulley, 1977) .
The stimuli that were used were adenosine di- (Cockbill, Heptinstall and Taylor, 1979 further three days after intravenous feeding had been terminated; 6 days after intravenous feeding had been terminated it had risen again. In another patient (no. 5) the threshold had returned to normal after only 3 days. Theywere always between 1 1 and 1 9 mmol/l (within the normal range) thus indicating that the infused lipid was being metabolized at an adequate rate.
Discussion
Platelets from different individuals vary in the extent to which they release labelled serotonin when stimulated by the aggregating agents ADP and adrenaline (Heptinstall and Mulley, 1977) . In this study, infusion of an Intralipid-based mixture did not, with one exception, significantly alter the extent of the platelet release reaction. The exception was in the case of platelets obtained from a patient with very severe Crohn's disease of the colon which failed to respond to high doses of intravenous prednisolone. The other patients studied were less ill and this may explain the difference in the results. Some of the authors' unpublished data suggest that severely injured patients may have a temporarily increased platelet reactivity; very severe large bowel Crohn's disease may be a parallel situation.
In all of the patients studied, the concentration of sodium arachidonate needed to induce platelets to aggregate and to release labelled serotonin was lower during infusion than before or after infusion. Such a change could result from activation of platelet cyclo-oxygenase, the enzyme responsible for converting arachidonate into the prostaglandins and thromboxanes that are responsible for the aggregation and release reaction. The apparent lack of effect of the infused Intralipid mixture on ADP-and adrenaline-induced platelet behaviour, however, tends to argue against cyclo-oxygenase activation as the explanation of this phenomenon since effects of ADP and adrenaline on platelets are also mediated by this enzyme.
It is possible that a reduction in the threshold level of arachidonate that was required to induce aggregation and release stems from changes that occur in the blood plasma itself during infusion of the Intralipid mixture. A reduced threshold might theoretically occur if the concentration of plasma proteins were reduced. However, any change in serum albumin that did occur, did not occur in parallel with the change in arachidonate threshold. Another possibility is that basal concentrations of circulating fatty acid were increased during the intravenous feeding. Certainly the normal triglyceride concentrations that were observed during intravenous feeding suggest that the lipid was being actively metabolized. Unfortunately, however, the free fatty acid levels were not measured.
If increased free fatty acid concentrations in the plasma were causing a decreased platelet release threshold to arachidonic acid in vitro, there are several ways in which this could have occurred. The mixing of the Intralipid and other nutrients may have caused release of free fatty acid. However, when platelet concentrates were treated with the mixture in vitro, no change in the release threshold to arachidonic acid was observed. Thus, lipolysis must have occurred in vivo only. The presence of heparin in some feeds might have released lipoprotein lipase into the plasma causing increased lipolysis; but, platelets from the three patients receiving heparin in the feed behaved in the same way as platelets from patients not receiving heparin. It is concluded that free fatty acid concentrations may have been elevated in the plasma of these patients owing to increased lipolysis in vivo; if so, low dose heparin infusion did not affect this.
No patient developed clinical evidence of bleeding or thrombotic tendency nor did the authors find any evidence that such problems might have developed owing to altered platelet behaviour. However, the change in threshold for arachidonic acid is disturbing. One of the fatty acids present in Intralipid is arachidonic acid itself. If the altered threshold to arachidonate is consequent to free fatty acids generated from Intralipid, it is theoretically possible that these free fatty acids could activate the platelets directly. Perhaps more rapid infusions than those used in this study would give rise to very high concentrations of free fatty acid, and should be avoided.
